Asenapine treatment of bipolar mania in a randomized, double-blind, placebo- and olanzapine-controlled trial (ARES 7501005)

被引：0
|
作者：
Hirschfeld, R. [1 ]
Panagides, J. [2 ]
Alphs, L. [3 ]
Cohen, M. [2 ]
Lancaster, S. [3 ]
Macek, T. [3 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
[2] Organon Int Inc, Roseland, NJ USA
[3] Pfizer Global R&D, Ann Arbor, MI USA
来源：
BIPOLAR DISORDERS | 2007年 / 9卷
关键词：
acute mania; asenapine; bipolar disorder; efficacy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Asenapine in acute mania: A randomized, double-blind, placebo- and olanzapine-controlled trial (ARES 7501004)
    Panagides, John
    McIntyre, Roger S.
    Alphs, Larry
    Cohen, Miriam
    Lancaster, Scott
    Macek, Tom
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 222S - 223S
  • [2] Treatment of mania in bipolar I disorder: a placebo- and olanzapine-control led trial of asenapine (ARES 7501005)
    McIntyre, R.
    Panagides, J.
    Alphs, L.
    Cohen, M.
    Lancaster, S.
    Macek, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S383 - S383
  • [3] Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
    Meltzer, Herbert Y.
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Phillips, Debra
    Xu, Jane
    Kalali, Amir H.
    Schweizer, Edward
    Pikalov, Andrei
    Loebel, Antony
    AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (09): : 957 - 967
  • [4] Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
    McIntyre, Roger S.
    Cohen, Miriam
    Zhao, Jun
    Alphs, Larry
    Macek, Thomas A.
    Panagides, John
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 122 (1-2) : 27 - 38
  • [5] Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial
    Niufan, Gu
    Tohen, Maunicio
    Qiuqing, Ang
    Fude, Yang
    Pope, Elizabeth
    McElroy, Heather
    Ming, Li
    Gaohua, Wang
    Xinbao, Zhang
    Huichun, Li
    Liang, Shu
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 105 (1-3) : 101 - 108
  • [6] Weight change and metabolic effects of asenapine in placebo- or olanzapine-controlled studies
    Landbloom, R.
    Zhao, J.
    Cazorla, P.
    Schoemaker, J.
    Mackle, M.
    Snow-Adami, L.
    Panagides, J.
    Szegedi, A.
    BIPOLAR DISORDERS, 2011, 13 : 65 - 65
  • [7] WEIGHT CHANGE AND METABOLIC EFFECTS OF ASENAPINE IN PLACEBO- OR OLANZAPINE-CONTROLLED STUDIES
    Zhao, J.
    Cazorla, P.
    Schoemaker, J.
    Mackle, M.
    Panagides, J.
    Karson, C.
    Szegedi, A.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [8] Asenapine versus olanzapine in acute mania: A double-blind extension study (ARES 7501006)
    Panagides, John
    McIntyre, Roger S.
    Alphs, Larry
    Cohen, Miriam
    Lancaster, Scott
    Macek, Tom
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 223S - 223S
  • [9] Asenapine versus olanzapine in acute mania: a double-blind extension study (ARES 7501006)
    McIntyre, R. S.
    Panagides, J.
    Alphs, L.
    Cohen, M.
    Keller, D. S.
    Macek, T.
    BIPOLAR DISORDERS, 2007, 9 : 76 - 76
  • [10] Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study
    Keck, P. E.
    Orsulak, P. J.
    Cutler, A. J.
    Sanchez, R.
    Torbeyns, A.
    Marcus, R. N.
    McQuade, R. D.
    Carson, W. H.
    JOURNAL OF AFFECTIVE DISORDERS, 2009, 112 (1-3) : 36 - 49
12345